Oncology Generics Medicines

The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")

This public procurement record has 2 releases in its history.

Award

05 Feb 2021 at 00:00

Tender

07 Aug 2020 at 01:00

Summary of the contracting process

The procurement process, initiated by The Common Services Agency (commonly known as NHS National Services Scotland), involves a tender titled "Oncology Generics Medicines." This tender falls under the health industry category and is located in Edinburgh, UK. The intended procurement method is an open procedure, and the submission period for bids is set to end on 14 September 2020. Successful suppliers will deliver a range of oncology generic medicines, with specific categories of goods broken down into thirty-nine lots.

This tender presents significant opportunities for businesses in the pharmaceutical sector, particularly those that specialise in the production and supply of oncology medications. Companies that can demonstrate compliance with UK and EMA Marketing Authorisations, as well as adhere to high-quality standards like BS EN ISO 9001, will have a competitive edge. This framework agreement is anticipated to foster collaboration among various suppliers, providing a substantial platform for growth and facilitating supply to NHS Scotland.

How relevant is this notice?

Notice Title

Oncology Generics Medicines

Notice Description

This Framework Agreement is for the supply of Oncology Generic medicines to NHS Scotland. The Goods have been separated into thirty-nine (39) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.

Lot Information

Lot 1 Bendamustine Powder For Solution For Infusion

Supply of Bendamustine Powder For Solution For Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 2 Capecitabine Tablets

Supply of Capecitabine Tablets to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 3 Carboplatin Injection

Supply of Carboplatin Injections to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 4 Cisplatin Injection

Supply of Cisplatin Injections to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 5 Cyclophosphamide Injection, Powder For Reconstitution

Supply of Cyclophosphamide Injection, Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 6 Cytarabine Injections

Supply of Cytarabine Injections to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 7 Dacarbazine Injections

Supply of Dacarbazine Injections to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 8 Disodium Folinate Injection

Supply of Disodium Folinate Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 9 Docetaxel Concentrate For Solution For Infusion

Supply of Docetaxel Concentrate For Solution For Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 10 Doxorubicin Hydrochloride Injections

Supply of Doxorubicin Hydrochloride Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 13 Fluorouracil 25MG/ML Injection

Supply of Fluorouracil 25MG/ML Injections to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 14 Fluorouracil 50MG/ML Injection

Supply of Fluorouracil 50MG/ML Injections to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 15 Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials

Supply of Gemcitabine 38MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 16 Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials

Supply of Gemcitabine 100MG/ML Concentrate For Solution For Infusion Vials to NHS Scotland The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 17 Gemcitabine Powder For Solution For Infusion Vials

Supply of Gemcitabine Powder For Solution For Infusion Vials to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 18 Idarubicin Hydrochlioride Injection Powder For Reconstitution

Supply of Idarubicin Hydrochlioride Injection Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 19 Ifosfamide Injection Powder For Reconstitution

Supply of Ifosfamide Injection Powder For Reconstitution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 20 Irinotecan Hydrochloride Injection

Supply of Irinotecan Hydrochloride Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 21 Lanreotide Injection Prefilled Syringes

Supply of Lanreotide Injection Prefilled Syringes to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 22 Methotrexate Without Preservatives Injection

Supply of Methotrexate Without Preservatives Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 23 Methotrexate Oral Solution

Supply of Methotrexate Oral Solution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 24 Mitomycin Injection Powder For Reconstitution

Supply of Mitomycin Injection Powder For Reconstitution to NHS Scotland. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 25 Oxaliplatin Vial Solution

Supply of Oxaliplatin Vial Solution to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 26 Paclitaxel Concentrate For Intravenous Infusion

Supply of Paclitaxel Concentrate For Intravenous Infusion to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 27 Temozolomide Capsules

Supply of Temozolomide Capsules to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 28 Vincristine Without Preservatives Injection

Supply of Vincristine Without Preservatives Injection to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 29 Vinorelbine Injection

Supply of Vinorelbine Injections to NHS Scotland. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 32 Dasatinib Tablets

Supply of dasatinib tablets to NHS Scotland. The Authority intends awarding each product line as a multi-supplier unranked framework agreement and it is envisaged a maximum of 3 Suppliers will be awarded. Full details of Goods and volumes can be found within the ITT documents.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 33 PEGFILGRASTIM 6MG PRE-FILLED SYRINGE

Supply of pegfilgrastim 6mg pre-filled syringe to NHS Scotland. The Authority has awarded this Lot as an unranked multi-supplier Framework to three (3) Framework Participants.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 34 APREPITANT CAPSULES

Supply of aprepitant capsules to NHS Scotland. Each product line within this Lot was grouped together and awarded to a single Framework Participant.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 35 TOPOTECAN CAPSULES

Supply of topotecan capsules to NHS Scotland. Each product line within this Lot will be grouped together and awarded to a single Framework Participant. Full details of Goods and volumes can be found within the ITT documents.

Renewal: he Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 36 TOPOTECAN CONCENTRATE FOR SOLUTION FOR INFUSION

Supply of topotecan concentrate for solution for infusion to NHS Scotland. Each product line within this Lot was grouped together and awarded to a single Framework Participant.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 37 OCTREOTIDE INJECTION

Supply of Octreotide Injection The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 38 Filgrastim Pre-Filled Syringe

Supply of Filgrastim Pre-Filled Syringe to NHS Scotland in a range of presentations. The Authority has awarded all presentations within this lot to a single supplier.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 39 ALL OTHER ONCOLOGY GENERIC PRODUCTS/PRESENTATIONS

Supply of all other products/presentations within this tender to NHS Scotland. Each product line was treated as an individual Lot, and has been awarded to a single supplier Participant.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 11 Imatinib

The supply of Imatinib to NHS Scotland. The Authority has awarded each product line as a ranked multi-supplier ranked framework agreement to seven (7) Framework Participants.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 12 Etoposide Injection

Supply of Etoposide Injection to NHS Scotland. The Authority has awarded award this Lot as a ranked multi-supplier framework to three (3) Framework Participants.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 30 Octreotide Vials Long Acting (Excluding Homecare)

Supply of octreotide vials long acting(excluding homecare) to NHS Scotland The Authority has awarded each product line as a multi-supplier unranked framework agreement to two (2) Framework participants.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Lot 31 Octreotide Vials Long Acting (Including Homecare)

Supply of octreotide vials long acting(including homecare) to NHS Scotland. The Authority has awarded each product line as a multi-supplier unranked framework agreement to two (2) Framework participants.

Renewal: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twenty-four (24) months by giving a minimum of three (3) months written notice of such extension(s).

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000626685
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB405960
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£51,839,881 £10M-£100M
Lots Value
£51,839,879 £10M-£100M
Awards Value
Not specified
Contracts Value
£29,082,301 £10M-£100M

Notice Dates

Publication Date
5 Feb 20215 years ago
Submission Deadline
14 Sep 2020Expired
Future Notice Date
Not specified
Award Date
16 Dec 20205 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Active, Complete
Awards Status
Not Specified
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland

Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland

Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
28
Supplier Names

Accord Healthcare Ltd

Altan Pharma Ltd.

Aspen Pharmacare UK Limited

Baxter Healthcare Ltd

Consilient Health Ltd

DRUGSRUS LTD

Dr Reddy's Laboratories (UK) Ltd

Fresenius Kabi Limited

Glenmark Pharmaceuticals Europe Ltd

Ipsen Limited

Kent Pharmaceuticals Ltd

Martindale Pharma

Morningside Pharmaceuticals Limited

Mylan

Napp Pharmaceuticals

Neon Healthcare Ltd

Novartis Pharmaceuticals UK Ltd

Pfizer Ltd

Ranbaxy (UK) Ltd

Rosemont Pharmaceuticals Ltd

Sandoz Ltd

Selective Supplies Ltd

Teva UK Limited

Tillomed Laboratories ltd

Waverley Pharma Europe Limited

Zentiva Pharma UK Ltd

hameln pharmaceuticals ltd

medac Pharma LLP

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...